Key result
P2Y12 i-T744C polymorphism linked to ~2-fold higher risk of large-artery atherosclerosis stroke.
Why the study?
Does the P2Y12 i-T744C polymorphism increase the risk of large-artery atherosclerosis stroke in adults?
Case-Control (n=649)
No
Does the P2Y12 i-T744C polymorphism increase the risk of large-artery atherosclerosis stroke in adults?
The P2Y12 i-T744C polymorphism is independently associated with an increased risk of large-artery atherosclerosis stroke and can be integrated into a clinical nomogram for risk prediction.
Answers are grounded in this paper and cite their sources.
Supports LAA stroke nomogram integration; leaves open prospective validation before clinical adoption.
Background: To evaluate the association of the purinergic receptor P2Y, G-protein coupled, 12 (P2Y12) gene polymorphisms with susceptibility to different etiological stroke subtypes. Methods: A total of 459 first-ever acute ischemic stroke patients were classified into large-artery atherosclerosis (LAA, n = 163), small-vessel occlusion (SVO, n = 204), and cardioembolism (CE, n = 92) based on the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. Direct sequencing was used to screen these three stroke subtypes and non-stroke controls for P2Y12 polymorphisms: a T→C transition at 744 nucleotides (nt) downstream of intron 5's start site (i-T744C) and a C→T transition at 34 nt downstream of exon 2's start site (C34T). Based on the results of multivariate logistic analyses, a prediction model was established via a nomogram that incorporated genomic and clinical variables to quantify the risk of LAA stroke. Results: Significant differences in the P2Y12 i-T744C genotype and allele frequencies were observed between LAA patients and controls. After adjusting for confounding factors, the dominant model (p = 0.009) and additive model (p = 0.023) revealed that the i-T744C polymorphism was significantly associated with increased susceptibility to LAA. No significant associations were found for the SVO and CE stroke subtypes. Moreover, the C34T polymorphism was not an independent factor for any stroke subtype. We further constructed a nomogram prediction model for LAA stroke based on genomic and clinical variables, including age, hypertension, smoking, high-density lipoprotein cholesterol, and the i-T744C polymorphism. This nomogram exhibited satisfactory accuracy and predictive power for LAA stroke, as demonstrated by the area under the curve, calibration plot, and decision curve analysis. Conclusion: The P2Y12 i-T744C polymorphism may serve as a predictor for LAA stroke. Furthermore, we constructed a genomic-clinical nomogram that may be valuable for predicting LAA stroke risk in the study population.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) conducted a case-control in Ischemic Stroke Subtypes (n=649). P2Y12 i-T744C polymorphism vs. Wild-type genotype / Non-stroke controls was evaluated on Susceptibility to large-artery atherosclerosis (LAA) stroke (OR 2.024, 95% CI 1.191-3.440, p=0.009). The P2Y12 i-T744C polymorphism was associated with an increased risk of large-artery atherosclerosis stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: